Statistics
Player Statistics
Every FPL player — points, price, form, ownership and upcoming fixtures. Filter by team and position.
Name | Fixtures | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| £5.0m | 33.6% | 53 | 10.7 | 10.6 | 15 | 2 | 3 | 236,261 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £6.0m | 37.8% | 53 | 12.3 | 8.8 | 6 | 3 | 5 | 202,590 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £6.2m | 18.3% | 46 | 8.3 | 7.4 | 3 | 1 | 1 | 12,231 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £7.7m | 68.3% | 45 | 8.0 | 5.8 | 12 | 5 | 3 | 226,710 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £15.6m | 74.8% | 45 | 7.0 | 2.9 | 6 | 6 | 0 | 37,082 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £7.8m | 29.7% | 44 | 6.3 | 5.6 | 10 | 4 | 2 | 112,697 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.6m | 8.6% | 43 | 7.0 | 9.3 | 1 | 2 | 0 | 34,489 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.8m | 27.7% | 41 | 6.3 | 7.1 | 4 | 1 | 4 | 27,964 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.2m | 15.6% | 40 | 8.3 | 6.5 | 1 | 3 | 2 | -28,912 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 4.4% | 40 | 7.3 | 8.0 | 8 | 1 | 0 | 16,185 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.9m | 51.9% | 38 | 5.3 | 6.4 | 9 | 1 | 2 | 57,590 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £7.8m | 44.1% | 38 | 6.3 | 4.9 | 9 | 4 | 1 | 147,196 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.1m | 6.6% | 37 | 7.7 | 7.3 | 6 | 3 | 2 | 54,916 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £9.7m | 24.9% | 36 | 5.0 | 3.7 | 8 | 2 | 4 | 58,002 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.7m | 13.4% | 36 | 3.3 | 7.7 | 2 | 0 | 0 | 12,124 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £6.0m | 17.9% | 36 | 5.3 | 6.0 | 6 | 1 | 1 | -353 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £8.4m | 13.5% | 36 | 7.7 | 4.3 | 3 | 2 | 3 | -4,538 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £7.9m | 6.2% | 36 | 7.3 | 4.6 | 10 | 1 | 3 | 20,802 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £9.6m | 16.9% | 34 | 4.0 | 3.5 | 2 | 3 | 0 | -27,699 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.1m | 43.7% | 33 | 6.0 | 5.4 | 3 | 0 | 0 | 1,904 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.6m | 5.5% | 33 | 6.0 | 5.0 | 13 | 2 | 1 | 4,569 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £9.0m | 15.4% | 33 | 3.3 | 3.7 | 0 | 4 | 0 | -154,640 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £7.9m | 20.0% | 33 | 4.0 | 4.2 | 8 | 3 | 1 | 3,816 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £6.1m | 7.3% | 32 | 3.7 | 5.2 | 1 | 3 | 0 | 29 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.5m | 21.6% | 32 | 7.7 | 7.1 | 9 | 0 | 0 | 25,962 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 1.5% | 32 | 5.3 | 7.1 | 6 | 1 | 0 | 6,341 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £7.2m | 8.5% | 32 | 1.3 | 4.4 | 0 | 1 | 3 | -113,253 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £11.9m | 35.9% | 32 | 1.7 | 2.7 | 1 | 3 | 1 | -135,901 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.0m | 2.5% | 31 | 3.3 | 6.2 | 3 | 2 | 0 | 496 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.3m | 20.9% | 31 | 4.3 | 5.8 | 0 | 1 | 1 | 17,486 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £6.8m | 20.1% | 30 | 2.0 | 4.4 | 1 | 2 | 0 | -35,134 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.1m | 3.9% | 30 | 2.0 | 4.9 | 0 | 1 | 2 | -48,840 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.5m | 2.6% | 30 | 5.7 | 5.5 | 3 | 0 | 0 | -963 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.0m | 5.6% | 30 | 5.0 | 6.0 | 2 | 0 | 0 | 2,186 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £8.0m | 15.4% | 30 | 4.0 | 3.8 | 2 | 1 | 2 | -42,961 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.0m | 3.6% | 29 | 5.3 | 5.8 | 5 | 0 | 3 | -575 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.6m | 8.4% | 29 | 7.0 | 5.2 | 1 | 2 | 3 | 33,672 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.6% | 29 | 6.3 | 5.8 | 8 | 1 | 3 | 1,905 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 4.5% | 29 | 5.0 | 5.8 | 2 | 0 | 1 | -1,895 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £6.0m | 2.4% | 29 | 3.3 | 4.8 | 2 | 1 | 0 | -1,422 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.5m | 6.0% | 28 | 4.0 | 6.2 | 4 | 2 | 0 | -5,050 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.2m | 13.9% | 28 | 1.0 | 6.7 | 1 | 1 | 0 | -14,135 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.1m | 6.2% | 28 | 1.3 | 6.8 | 3 | 1 | 0 | -2,460 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.6m | 4.0% | 28 | 5.3 | 5.0 | 2 | 2 | 1 | -6,406 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.5m | 4.3% | 28 | 6.0 | 5.1 | 1 | 0 | 0 | 1,283 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.5m | 7.5% | 28 | 6.0 | 5.1 | 9 | 0 | 0 | 4,854 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.1m | 8.2% | 28 | 3.7 | 4.6 | 0 | 1 | 3 | 13,286 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £7.9m | 22.1% | 27 | 4.0 | 3.4 | 2 | 0 | 0 | -36,292 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £7.3m | 10.7% | 27 | 4.7 | 3.7 | 7 | 0 | 3 | 7,844 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.4m | 2.4% | 27 | 7.3 | 5.0 | 10 | 1 | 2 | 16,629 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 3.7% | 27 | 4.7 | 6.0 | 6 | 1 | 0 | 1,596 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.6m | 3.4% | 27 | 5.3 | 5.9 | 0 | 0 | 0 | -17,038 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.1m | 7.4% | 27 | 1.3 | 6.6 | 1 | 0 | 0 | -7,609 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 3.6% | 27 | 6.0 | 5.4 | 3 | 0 | 0 | 8,131 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.9m | 6.3% | 27 | 5.7 | 5.5 | 3 | 1 | 0 | 1,554 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.4m | 4.4% | 26 | 2.0 | 4.8 | 5 | 0 | 2 | -2,170 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.5m | 9.1% | 26 | 5.0 | 4.7 | 1 | 0 | 0 | -5,692 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.7m | 8.6% | 26 | 4.7 | 4.6 | 6 | 3 | 0 | -6,846 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.6m | 4.7% | 26 | 2.3 | 4.6 | 2 | 2 | 0 | 2,041 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 3.0% | 26 | 2.0 | 6.5 | 2 | 0 | 1 | -699 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 7.7% | 26 | 5.7 | 6.5 | 1 | 2 | 2 | -315 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.5m | 1.5% | 26 | 4.0 | 4.7 | 4 | 0 | 1 | 805 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.9m | 1.2% | 25 | 6.0 | 4.2 | 4 | 1 | 1 | 2,278 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £6.0m | 3.4% | 25 | 4.7 | 4.2 | 7 | 1 | 3 | 13,519 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.5m | 1.5% | 25 | 6.0 | 5.6 | 4 | 1 | 1 | -120 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £6.5m | 16.0% | 25 | 5.3 | 3.8 | 0 | 0 | 0 | -8,037 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.5m | 2.2% | 25 | 4.0 | 4.5 | 2 | 0 | 1 | -2,855 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.5m | 1.6% | 24 | 2.0 | 4.4 | 2 | 1 | 1 | -2,736 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.3% | 24 | 5.7 | 5.3 | 5 | 0 | 0 | 668 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.0m | 8.7% | 24 | 3.0 | 6.0 | 0 | 0 | 0 | -3,829 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £6.0m | 22.6% | 24 | 4.7 | 4.0 | 2 | 2 | 1 | -16,939 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.7m | 5.4% | 24 | 6.0 | 4.2 | 0 | 3 | 0 | -41,033 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.6m | 7.5% | 23 | 2.3 | 5.0 | 0 | 1 | 0 | -13,873 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.6m | 8.5% | 23 | 1.7 | 4.1 | 1 | 0 | 2 | -24,910 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 1.5% | 23 | 4.3 | 5.1 | 1 | 1 | 0 | -1,508 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.5m | 0.3% | 23 | 4.0 | 4.2 | 9 | 1 | 2 | 252 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.8m | 5.9% | 23 | 2.3 | 4.0 | 1 | 0 | 2 | -12,506 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.5m | 1.9% | 23 | 4.3 | 4.2 | 6 | 0 | 0 | 1,239 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.4m | 3.4% | 23 | 1.7 | 4.3 | 2 | 0 | 1 | -6,163 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.0m | 6.1% | 22 | 3.7 | 4.4 | 2 | 0 | 0 | -2,693 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.6% | 22 | 6.0 | 4.9 | 1 | 0 | 1 | -2,102 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.4m | 1.5% | 22 | 6.7 | 5.0 | 9 | 0 | 0 | 2,493 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.4m | 0.9% | 22 | 4.3 | 4.1 | 1 | 0 | 1 | -630 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.4m | 3.1% | 22 | 4.3 | 4.1 | 0 | 0 | 0 | 415 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.0m | 0.6% | 22 | 3.7 | 4.4 | 0 | 2 | 0 | 257 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.5m | 0.6% | 22 | 3.0 | 4.0 | 7 | 2 | 0 | -547 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £7.5m | 6.6% | 21 | 1.7 | 2.8 | 2 | 2 | 0 | -13,095 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.5m | 3.8% | 21 | 3.3 | 4.7 | 1 | 2 | 0 | -8,192 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.3% | 21 | 5.0 | 4.2 | 2 | 1 | 0 | 14 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.0m | 2.5% | 21 | 4.7 | 5.2 | 11 | 1 | 0 | -316 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £6.3m | 3.8% | 21 | 4.3 | 3.3 | 6 | 0 | 1 | 2,454 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.3m | 1.7% | 21 | 4.0 | 4.0 | 7 | 0 | 1 | 1,559 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 15.8% | 21 | 4.0 | 4.7 | 3 | 0 | 0 | -4,531 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.9m | 0.2% | 20 | 5.3 | 3.4 | 5 | 1 | 1 | 844 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.9m | 0.2% | 20 | 6.7 | 4.1 | 18 | 2 | 1 | 16,404 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.0m | 0.9% | 20 | 5.0 | 5.0 | 0 | 1 | 0 | 1,018 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.5m | 0.8% | 20 | 1.7 | 3.6 | 1 | 1 | 0 | -3,173 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.5m | 4.1% | 20 | 4.7 | 4.4 | 2 | 0 | 0 | 3,705 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.5m | 1.2% | 20 | 2.3 | 4.4 | 0 | 0 | 2 | -2,602 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.8m | 0.4% | 20 | 4.7 | 3.4 | 2 | 1 | 0 | 1,159 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £7.3m | 5.3% | 20 | 3.7 | 2.7 | 2 | 0 | 2 | -5,680 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £6.9m | 29.4% | 20 | 1.7 | 2.9 | 0 | 1 | 0 | -80,821 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.0m | 7.0% | 20 | 1.7 | 4.0 | 1 | 0 | 1 | -34,601 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.7m | 3.1% | 20 | 2.3 | 3.5 | 2 | 1 | 1 | -3,264 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.0m | 0.3% | 19 | 4.0 | 3.8 | 4 | 0 | 1 | 69 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.9m | 0.9% | 19 | 6.3 | 3.2 | 5 | 1 | 2 | 8,509 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £6.5m | 2.3% | 19 | 5.0 | 2.9 | 9 | 2 | 0 | 32,899 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £6.5m | 1.4% | 19 | 3.0 | 2.9 | 5 | 1 | 1 | 1,592 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.4m | 0.7% | 19 | 3.7 | 3.5 | 7 | 0 | 1 | -256 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £6.0m | 0.7% | 19 | 5.0 | 3.2 | 5 | 1 | 1 | 57 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £6.7m | 2.0% | 18 | 5.7 | 2.7 | 9 | 2 | 0 | 19,377 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.0m | 1.9% | 18 | 2.0 | 3.6 | 2 | 0 | 0 | -1,298 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.4m | 0.4% | 18 | 4.7 | 3.3 | 3 | 1 | 0 | 362 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.9m | 0.6% | 18 | 4.7 | 3.7 | 4 | 0 | 0 | -255 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 0.4% | 18 | 2.3 | 3.6 | 2 | 0 | 1 | -702 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.4m | 0.7% | 18 | 4.0 | 3.3 | 4 | 0 | 0 | 1,022 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.5m | 0.1% | 18 | 5.3 | 4.0 | 4 | 0 | 1 | 900 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £6.1m | 3.2% | 18 | 0.0 | 3.0 | 0 | 2 | 0 | -22,353 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.0m | 0.1% | 18 | 2.7 | 3.6 | 2 | 1 | 1 | -153 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.8m | 0.6% | 17 | 5.0 | 3.5 | 8 | 1 | 1 | 2,045 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 1.0% | 17 | 4.7 | 3.8 | 2 | 0 | 1 | 1,178 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.5m | 5.0% | 17 | 2.0 | 3.8 | 2 | 0 | 1 | -3,936 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.5m | 0.8% | 17 | 2.0 | 3.1 | 2 | 0 | 2 | -1,938 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £6.5m | 0.8% | 17 | 1.3 | 2.6 | 2 | 1 | 1 | -78 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.9m | 1.0% | 17 | 5.3 | 2.9 | 6 | 0 | 0 | 775 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.8m | 1.4% | 17 | 3.0 | 2.9 | 3 | 0 | 0 | -1,824 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.4m | 2.4% | 17 | 3.7 | 3.9 | 0 | 0 | 1 | -4,483 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.0m | 3.7% | 17 | 2.7 | 3.4 | 1 | 0 | 0 | -3,217 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.5m | 1.3% | 17 | 1.3 | 3.1 | 2 | 1 | 1 | -382 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.6m | 17.3% | 16 | 3.7 | 3.5 | 4 | 0 | 0 | -1,683 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.3m | 7.0% | 16 | 1.7 | 2.5 | 0 | 0 | 2 | -75,321 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.4m | 0.4% | 16 | 1.3 | 3.0 | 0 | 0 | 1 | -1,323 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.9m | 0.5% | 16 | 0.0 | 2.7 | 0 | 2 | 0 | -858 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.7% | 16 | 3.7 | 3.6 | 0 | 0 | 1 | -276 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.0m | 0.0% | 16 | 4.7 | 3.2 | 7 | 0 | 1 | 259 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.5m | 0.3% | 16 | 3.0 | 2.9 | 3 | 0 | 0 | 414 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £6.1m | 7.3% | 16 | 2.0 | 2.6 | 2 | 1 | 0 | -7,930 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.1% | 16 | 4.0 | 3.2 | 3 | 0 | 0 | 291 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.8% | 16 | 4.3 | 4.0 | 10 | 1 | 0 | 902 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £6.9m | 3.8% | 16 | 4.0 | 2.3 | 3 | 1 | 0 | 7,490 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.0m | 1.5% | 16 | 2.3 | 3.2 | 2 | 0 | 0 | -1,785 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.5m | 0.1% | 16 | 3.0 | 2.9 | 4 | 0 | 0 | -136 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.4m | 1.8% | 16 | 1.0 | 3.0 | 3 | 0 | 0 | -1,742 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.9m | 0.6% | 15 | 2.7 | 2.5 | 0 | 1 | 0 | -4,930 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.5m | 0.1% | 15 | 5.0 | 2.7 | 3 | 1 | 1 | 651 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.9m | 6.6% | 15 | 2.0 | 2.5 | 2 | 0 | 1 | -8,609 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £6.0m | 0.2% | 15 | 3.7 | 2.5 | 4 | 0 | 0 | 169 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.5m | 0.6% | 15 | 5.0 | 3.3 | 3 | 0 | 0 | 1,651 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.7% | 15 | 1.0 | 3.8 | 1 | 0 | 0 | -148 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.9m | 0.1% | 15 | 2.3 | 3.1 | 4 | 0 | 1 | -5 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.3m | 0.2% | 15 | 2.3 | 2.8 | 4 | 1 | 1 | -106 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.9m | 0.3% | 15 | 3.0 | 3.1 | 1 | 0 | 2 | 66 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.0m | 0.8% | 15 | 2.0 | 3.0 | 0 | 0 | 0 | -365 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £6.3m | 18.8% | 15 | 0.7 | 2.4 | 0 | 1 | 1 | -24,022 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.0m | 0.1% | 15 | 2.3 | 3.0 | 2 | 0 | 0 | -169 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.5m | 0.3% | 15 | 2.0 | 3.3 | 1 | 0 | 1 | -551 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.5m | 0.8% | 14 | 2.7 | 2.5 | 2 | 0 | 0 | -424 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £7.8m | 9.3% | 14 | 3.3 | 1.8 | 4 | 1 | 1 | -10,709 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.1% | 14 | 3.3 | 3.1 | 0 | 0 | 0 | -4 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.8m | 0.2% | 14 | 4.0 | 2.9 | 4 | 0 | 0 | -48 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.5m | 1.8% | 14 | 2.0 | 2.5 | 1 | 0 | 2 | -2,753 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 11.7% | 14 | 2.3 | 3.5 | 2 | 0 | 0 | -14,605 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.5m | 0.1% | 14 | 3.0 | 3.1 | 1 | 0 | 0 | -17 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.3m | 2.1% | 14 | 2.7 | 2.6 | 1 | 0 | 0 | -1,753 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.0m | 2.2% | 14 | 2.0 | 2.8 | 0 | 0 | 0 | -2,615 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.0m | 1.5% | 14 | 1.3 | 2.8 | 0 | 0 | 0 | -1,194 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.8m | 0.9% | 14 | 3.7 | 2.4 | 7 | 1 | 0 | 12,035 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.8m | 1.8% | 14 | 0.7 | 2.9 | 0 | 0 | 0 | -12,952 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.0m | 0.3% | 13 | 2.3 | 2.6 | 1 | 0 | 0 | -79 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.0m | 0.6% | 13 | 2.0 | 2.6 | 0 | 0 | 0 | -350 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.9m | 0.1% | 13 | 2.3 | 2.7 | 0 | 0 | 0 | -16 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.9m | 0.3% | 13 | 2.7 | 2.7 | 2 | 0 | 0 | -156 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.6% | 13 | 0.3 | 2.6 | 1 | 0 | 0 | -1,245 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.4m | 1.3% | 13 | 2.7 | 2.4 | 2 | 0 | 0 | -46 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £7.4m | 0.9% | 13 | 4.3 | 1.8 | 12 | 1 | 1 | 17,300 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.9m | 9.3% | 13 | 2.7 | 2.7 | 2 | 0 | 0 | -11,571 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.5m | 1.4% | 13 | 0.0 | 2.9 | 0 | 0 | 1 | -6,462 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.5m | 0.2% | 13 | 1.7 | 2.4 | -2 | 0 | 0 | -630 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.8m | 0.2% | 13 | 2.3 | 2.7 | 3 | 0 | 0 | -5 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.3m | 1.5% | 12 | 0.0 | 2.3 | 0 | 0 | 0 | -4,300 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.3m | 1.5% | 12 | 2.0 | 1.9 | 2 | 0 | 0 | -567 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.0m | 4.7% | 12 | 2.3 | 2.4 | 3 | 0 | 0 | -3,503 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.0m | 0.2% | 12 | 1.0 | 2.4 | 1 | 1 | 0 | -592 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 1.4% | 12 | 2.7 | 2.7 | 0 | 0 | 0 | -4,747 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.4m | 0.2% | 12 | 0.3 | 2.2 | 0 | 1 | 0 | -366 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.1% | 12 | 2.3 | 2.4 | 1 | 0 | 0 | -106 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.8m | 7.7% | 12 | 1.7 | 2.5 | 2 | 0 | 1 | -17,502 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.3m | 6.9% | 12 | 1.7 | 2.8 | 3 | 0 | 1 | -11,303 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.5m | 0.1% | 12 | 1.3 | 2.2 | 0 | 0 | 0 | -195 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.4m | 0.9% | 12 | 0.0 | 2.2 | 0 | 0 | 0 | -2,856 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.8m | 2.0% | 12 | 2.7 | 2.1 | 0 | 1 | 0 | -17,638 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.3m | 0.2% | 12 | 3.0 | 2.3 | 3 | 1 | 0 | 278 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.9m | 0.2% | 12 | 2.7 | 2.4 | 3 | 0 | 0 | 53 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.9m | 2.3% | 12 | 1.0 | 2.4 | 1 | 0 | 0 | -2,442 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.4m | 0.6% | 11 | 1.0 | 2.0 | 2 | 0 | 0 | -317 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.5m | 0.4% | 11 | 1.3 | 2.4 | 1 | 0 | 0 | -301 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.3% | 11 | 1.7 | 2.4 | 3 | 0 | 0 | -153 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.0m | 0.2% | 11 | 1.3 | 2.2 | 1 | 0 | 0 | -350 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.9m | 0.1% | 11 | 1.7 | 2.2 | 0 | 0 | 0 | -114 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.5m | 0.1% | 11 | 3.7 | 2.4 | 3 | 0 | 0 | 182 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.9m | 0.1% | 11 | 2.7 | 1.9 | 2 | 0 | 0 | -66 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.4m | 0.2% | 11 | 1.0 | 2.0 | 1 | 0 | 1 | -208 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.0m | 0.1% | 11 | 1.7 | 2.2 | 4 | 0 | 1 | -36 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.5m | 0.0% | 11 | 3.3 | 2.0 | 7 | 0 | 1 | 184 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £6.3m | 9.5% | 11 | 2.3 | 1.7 | 5 | 0 | 0 | -16,431 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.9m | 1.3% | 11 | 1.7 | 1.6 | 1 | 0 | 0 | -2,826 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.6m | 2.4% | 11 | 2.7 | 2.0 | 2 | 1 | 0 | -10,233 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.5m | 0.2% | 11 | 0.3 | 2.4 | 0 | 0 | 0 | -200 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.3m | 2.3% | 11 | 0.7 | 2.6 | 1 | 0 | 0 | -5,536 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.4m | 0.9% | 10 | 0.0 | 1.9 | 0 | 0 | 0 | -1,982 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.3m | 0.4% | 10 | 1.7 | 1.9 | 4 | 0 | 2 | 672 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.9m | 0.2% | 10 | 2.3 | 2.0 | 5 | 0 | 1 | 821 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.3m | 0.3% | 10 | 2.3 | 2.3 | 7 | 1 | 0 | 1,510 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.3m | 0.2% | 10 | 1.3 | 1.9 | 2 | 0 | 0 | -261 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.8m | 0.4% | 10 | 2.7 | 1.7 | 0 | 0 | 1 | -2,271 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £6.5m | 0.7% | 10 | 2.3 | 1.5 | 2 | 0 | 0 | 3,858 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £6.5m | 0.2% | 10 | 2.7 | 1.5 | 3 | 0 | 1 | 3,046 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.4m | 0.4% | 9 | 0.3 | 2.0 | 0 | 0 | 0 | -1,367 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 1.1% | 9 | 0.7 | 2.0 | 0 | 0 | 0 | -3,733 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.0m | 0.0% | 9 | 2.3 | 1.8 | 1 | 1 | 0 | -57 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 2.9% | 9 | 1.0 | 2.0 | 0 | 0 | 0 | -2,126 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.4m | 2.9% | 9 | 1.3 | 1.7 | -1 | 0 | 0 | -5,572 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.0m | 0.2% | 9 | 0.7 | 1.8 | 1 | 0 | 0 | -246 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.9m | 0.1% | 9 | 1.7 | 1.8 | 0 | 0 | 0 | -80 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.0m | 0.8% | 9 | 1.7 | 1.8 | 0 | 0 | 0 | 1,332 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.8m | 0.1% | 9 | 1.3 | 1.9 | 0 | 0 | 0 | -145 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.8m | 0.1% | 9 | 3.0 | 1.9 | 8 | 1 | 0 | 142 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.5m | 0.5% | 9 | 0.7 | 1.6 | 1 | 0 | 1 | -499 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 0.0% | 9 | 3.0 | 1.8 | 8 | 1 | 0 | 182 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.0% | 9 | 2.3 | 1.8 | 0 | 1 | 0 | 7 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £8.0m | 2.0% | 9 | 2.7 | 1.1 | 2 | 0 | 0 | 952 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.4m | 1.3% | 9 | 0.0 | 1.7 | 0 | 0 | 0 | -1,705 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.8m | 1.5% | 9 | -0.7 | 1.3 | 0 | 0 | 2 | -3,230 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.9m | 1.3% | 9 | 1.7 | 1.8 | 3 | 0 | 0 | -873 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £7.0m | 2.1% | 9 | 1.7 | 1.3 | 1 | 0 | 0 | -2,868 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.4m | 6.1% | 9 | 0.3 | 1.7 | 0 | 0 | 0 | -35,135 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.4m | 0.3% | 9 | 0.7 | 2.0 | 2 | 0 | 0 | 241 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.4m | 0.2% | 9 | 0.0 | 2.0 | 2 | 0 | 0 | -210 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.0m | 0.0% | 8 | 2.0 | 1.6 | 3 | 0 | 0 | 60 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £6.3m | 0.4% | 8 | 1.0 | 1.3 | 1 | 0 | 0 | -402 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 0.2% | 8 | 1.7 | 1.6 | 0 | 0 | 0 | -518 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.7% | 8 | 0.0 | 1.8 | 0 | 0 | 2 | -3,809 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.4m | 0.4% | 8 | 0.3 | 1.8 | 0 | 1 | 0 | -1,053 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £6.5m | 0.5% | 8 | 2.0 | 1.2 | 2 | 0 | 0 | -179 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.4m | 0.1% | 8 | 0.0 | 1.5 | 0 | 0 | 1 | -244 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.0m | 1.1% | 8 | 0.7 | 1.6 | 1 | 1 | 0 | -1,586 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.3m | 0.4% | 8 | 1.0 | 1.5 | 1 | 0 | 0 | -589 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.4m | 0.4% | 8 | 1.0 | 1.5 | 1 | 0 | 1 | -370 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.8m | 1.0% | 8 | 0.3 | 1.4 | -1 | 0 | 1 | -2,114 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.9m | 1.5% | 8 | 1.3 | 1.6 | 0 | 0 | 0 | -3,736 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £7.0m | 1.4% | 8 | 0.3 | 1.1 | 0 | 1 | 0 | -8,186 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.8m | 0.1% | 8 | 2.3 | 1.4 | 0 | 1 | 0 | -64 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.9m | 0.1% | 8 | 1.7 | 1.6 | 0 | 0 | 0 | -45 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.4m | 2.1% | 8 | 0.7 | 1.8 | 0 | 0 | 0 | -6,441 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.4m | 0.5% | 8 | 2.3 | 1.5 | 1 | 0 | 0 | -481 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.7m | 0.2% | 8 | 0.3 | 1.4 | 0 | 0 | 0 | -287 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.7m | 0.7% | 8 | 1.7 | 1.4 | 1 | 0 | 0 | -917 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 0.2% | 7 | 1.7 | 1.6 | 1 | 0 | 0 | -81 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.4m | 0.1% | 7 | 0.3 | 1.3 | 1 | 0 | 1 | -23 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.9m | 0.2% | 7 | 0.0 | 1.4 | 0 | 0 | 0 | -388 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.0% | 7 | 2.3 | 1.6 | 7 | 1 | 0 | 511 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.3% | 7 | 0.7 | 1.6 | 2 | 0 | 0 | -180 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.5% | 7 | 0.3 | 1.6 | 0 | 0 | 0 | -484 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.5m | 0.1% | 7 | 2.0 | 1.3 | 1 | 1 | 0 | -65 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.3m | 0.6% | 7 | 0.0 | 1.6 | 0 | 0 | 0 | -1,594 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.8m | 0.2% | 7 | 0.0 | 1.5 | 0 | 1 | 0 | -784 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.4m | 4.5% | 6 | -0.3 | 1.4 | 0 | 0 | 0 | -9,112 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.1% | 6 | 1.3 | 1.3 | 1 | 0 | 0 | -241 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.1% | 6 | 1.0 | 1.3 | 1 | 0 | 0 | -32 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 0.0% | 6 | 2.0 | 1.2 | 0 | 1 | 0 | 8 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.0m | 7.5% | 6 | 0.0 | 1.5 | 0 | 0 | 0 | -20,111 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.0m | 0.1% | 6 | 2.0 | 1.5 | 0 | 0 | 0 | 89 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.9m | 0.0% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | -67 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.0m | 0.0% | 6 | 0.0 | 1.2 | 0 | 1 | 0 | -57 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.9m | 0.1% | 6 | 0.0 | 1.2 | 0 | 0 | 0 | -130 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £6.2m | 1.4% | 6 | 0.7 | 1.0 | 1 | 0 | 0 | -1,692 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.4m | 5.4% | 6 | 1.7 | 1.1 | 1 | 0 | 0 | -12,538 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.3m | 0.1% | 6 | 1.7 | 1.1 | 3 | 0 | 0 | -9 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.7m | 0.4% | 5 | 1.0 | 0.9 | 1 | 0 | 0 | -144 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.3m | 0.5% | 5 | 0.7 | 0.9 | 0 | 0 | 0 | -877 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.9m | 0.1% | 5 | 1.0 | 1.0 | 1 | 0 | 0 | -37 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.5m | 0.0% | 5 | 1.0 | 1.1 | 1 | 0 | 0 | -15 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.9m | 0.2% | 5 | 1.3 | 1.0 | -2 | 0 | 0 | -623 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.9m | 0.9% | 5 | 1.3 | 0.8 | 1 | 0 | 0 | -5,170 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.9m | 0.9% | 5 | 0.7 | 1.0 | 1 | 0 | 0 | -1,761 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.8m | 0.8% | 5 | 1.3 | 1.0 | 2 | 0 | 0 | -1,127 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £6.3m | 0.7% | 5 | 1.0 | 0.8 | 1 | 0 | 0 | -346 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.3m | 0.1% | 5 | 0.7 | 0.9 | 0 | 0 | 0 | -45 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.3m | 0.1% | 5 | 0.3 | 0.9 | 0 | 0 | 0 | -49 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.9m | 1.2% | 5 | 0.0 | 1.0 | 0 | 0 | 0 | -2,199 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.3m | 0.0% | 5 | 1.0 | 0.9 | 1 | 0 | 0 | -52 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.6% | 5 | 0.7 | 1.2 | 0 | 0 | 0 | -288 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.7m | 0.4% | 5 | 0.7 | 0.9 | 1 | 0 | 0 | -234 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.0m | 0.0% | 5 | 1.0 | 1.0 | 2 | 0 | 0 | 185 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.8m | 0.5% | 5 | 1.0 | 1.0 | 3 | 0 | 0 | 75 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.5m | 0.2% | 5 | 0.3 | 0.9 | 0 | 0 | 0 | 59 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.8m | 0.4% | 5 | 1.0 | 1.0 | 1 | 0 | 0 | -371 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.8m | 0.9% | 5 | 1.0 | 0.9 | 1 | 0 | 0 | -566 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.8m | 3.3% | 5 | 0.7 | 0.9 | 2 | 0 | 0 | -2,655 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.3m | 0.0% | 5 | 0.0 | 0.9 | 0 | 0 | 1 | -22 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £6.2m | 1.1% | 4 | 0.7 | 0.6 | 0 | 0 | 0 | -1,839 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.2m | 0.2% | 4 | 0.7 | 0.6 | 2 | 0 | 0 | 445 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.5m | 0.0% | 4 | 2.0 | 0.7 | 2 | 0 | 0 | 21 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.5m | 0.2% | 4 | 0.7 | 0.7 | 0 | 0 | 0 | -38 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.1% | 4 | 0.7 | 0.9 | 0 | 0 | 0 | -97 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.0m | 0.1% | 4 | 0.7 | 0.8 | 1 | 0 | 0 | -12 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.0m | 0.5% | 4 | 0.0 | 1.0 | 0 | 0 | 0 | -1,766 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.9m | 0.6% | 4 | 0.3 | 0.8 | 0 | 0 | 0 | -63 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.3m | 0.1% | 4 | 0.3 | 0.8 | 1 | 0 | 0 | -75 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.5m | 0.0% | 4 | 1.3 | 0.9 | 1 | 0 | 0 | -6 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.4m | 0.4% | 4 | 0.7 | 0.7 | 1 | 0 | 0 | -152 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.0% | 4 | 1.0 | 0.8 | 1 | 0 | 0 | 10 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.4m | 0.5% | 4 | 0.7 | 0.9 | 1 | 0 | 0 | 1,111 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.9m | 0.0% | 4 | 0.3 | 0.8 | 0 | 0 | 0 | -20 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.4m | 0.4% | 4 | 1.3 | 0.9 | 2 | 0 | 0 | 557 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.4m | 0.1% | 4 | 1.3 | 0.7 | 2 | 0 | 0 | -32 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.8m | 0.1% | 4 | 1.3 | 0.8 | 2 | 0 | 0 | -7 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.8m | 0.0% | 4 | 0.7 | 0.8 | 1 | 0 | 0 | 13 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.8m | 0.5% | 4 | 0.0 | 0.8 | 0 | 0 | 0 | -1,350 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.1% | 4 | 1.0 | 0.8 | 0 | 0 | 1 | -350 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.9m | 0.5% | 4 | 0.0 | 0.7 | 0 | 0 | 1 | -561 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.8m | 0.3% | 4 | 0.0 | 0.7 | 0 | 0 | 1 | -187 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £6.0m | 0.1% | 4 | 1.0 | 0.7 | 0 | 0 | 0 | 6 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £6.3m | 0.4% | 4 | 1.0 | 0.6 | 1 | 0 | 0 | 50 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.0m | 0.2% | 4 | 0.7 | 0.8 | 1 | 0 | 0 | -15 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.5m | 0.0% | 4 | 1.0 | 0.7 | 1 | 0 | 0 | -27 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.2m | 0.9% | 3 | 0.3 | 0.6 | 1 | 0 | 0 | -932 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £7.1m | 3.7% | 3 | 0.7 | 0.4 | 1 | 0 | 0 | -10,419 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.4m | 0.3% | 3 | 0.3 | 0.7 | 0 | 0 | 0 | -199 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.8m | 0.3% | 3 | 0.0 | 0.5 | 0 | 0 | 0 | -373 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £6.0m | 0.1% | 3 | 1.0 | 0.5 | 1 | 0 | 0 | -98 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £6.0m | 0.1% | 3 | 0.7 | 0.5 | 1 | 0 | 0 | 5 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.0m | 0.1% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | -43 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.4m | 0.3% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -233 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.1% | 3 | 1.0 | 0.7 | 1 | 0 | 0 | -18 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 0.0% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | -26 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.3m | 5.3% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | -19,773 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.3m | 1.0% | 3 | 0.7 | 0.6 | 2 | 0 | 0 | 852 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.4m | 0.1% | 3 | 0.7 | 0.6 | 0 | 0 | 0 | -151 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.3m | 0.1% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | -66 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.4m | 0.3% | 3 | -0.7 | 0.6 | 0 | 0 | 0 | -940 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.3m | 0.1% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -63 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.4m | 0.2% | 3 | 0.3 | 0.7 | 0 | 0 | 0 | -657 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.8m | 0.3% | 3 | 1.0 | 0.6 | 1 | 0 | 0 | -183 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.0m | 0.2% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | 30 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.5m | 0.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -20 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.3m | 0.2% | 3 | 0.3 | 0.6 | 0 | 0 | 0 | -266 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.0% | 3 | 0.7 | 0.6 | 1 | 0 | 0 | -3 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.1% | 3 | 1.0 | 0.6 | 1 | 0 | 0 | 242 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £3.9m | 1.2% | 3 | 0.3 | 0.8 | 0 | 0 | 0 | 2,070 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.4m | 1.0% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -858 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.9m | 0.1% | 3 | 0.7 | 0.6 | 0 | 0 | 0 | -362 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.3m | 1.7% | 3 | 0.7 | 0.6 | 1 | 0 | 0 | -2,061 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.9m | 0.2% | 3 | 1.0 | 0.6 | 3 | 0 | 0 | 2,189 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.4m | 0.4% | 3 | 0.0 | 0.7 | 0 | 0 | 0 | -1,664 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.3m | 0.4% | 3 | 1.0 | 0.6 | 1 | 0 | 0 | 235 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.9m | 0.1% | 3 | 0.3 | 0.5 | 0 | 0 | 0 | 85 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.9m | 0.1% | 3 | 0.7 | 0.6 | 0 | 0 | 0 | -69 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.4m | 0.0% | 3 | 0.3 | 0.7 | 0 | 0 | 0 | -14 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.0m | 0.0% | 3 | 0.0 | 0.6 | 0 | 0 | 0 | -91 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £6.5m | 0.6% | 2 | 0.7 | 0.3 | 1 | 0 | 0 | -524 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.9m | 0.0% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -10 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.4m | 0.1% | 2 | 0.7 | 0.4 | 0 | 0 | 0 | -29 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.9m | 0.6% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -1,036 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.3m | 0.0% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -43 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.4m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -25 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.3m | 0.1% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -43 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £6.2m | 0.7% | 2 | 0.7 | 0.3 | 1 | 0 | 0 | 201 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.4m | 6.7% | 2 | 0.3 | 0.5 | 0 | 0 | 0 | -8,510 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £6.3m | 1.2% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -1,420 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.9m | 0.0% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -3 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.9m | 0.1% | 2 | 0.3 | 0.4 | 1 | 0 | 0 | -35 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.3m | 0.0% | 2 | 0.7 | 0.4 | 1 | 0 | 0 | -14 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.4m | 0.5% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -1,363 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.0m | 0.0% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | -53 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.9m | 0.0% | 2 | 0.3 | 0.4 | 1 | 0 | 0 | 24 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.5m | 3.5% | 2 | 0.3 | 0.4 | 1 | 0 | 0 | -204 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.8m | 0.1% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -37 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 2 | 0.7 | 0.4 | 1 | 0 | 0 | -23 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.9m | 0.1% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -58 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.3m | 0.1% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -50 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.5m | 0.2% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -259 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.4m | 0.1% | 2 | 0.0 | 0.5 | 0 | 0 | 0 | 217 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.3m | 0.3% | 2 | 0.3 | 0.5 | 1 | 0 | 0 | -253 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.2% | 2 | 0.3 | 0.4 | 0 | 0 | 0 | -38 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.8m | 0.1% | 2 | 0.3 | 0.3 | 1 | 0 | 0 | -102 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.4m | 0.0% | 2 | 0.3 | 0.4 | 1 | 0 | 0 | 2 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.9m | 0.6% | 2 | 0.0 | 0.3 | 0 | 0 | 0 | -1,006 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.8m | 0.0% | 2 | 0.0 | 0.4 | 0 | 0 | 0 | -52 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.3m | 0.1% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | -108 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.5m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -31 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -39 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 0.3% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -104 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.4m | 0.2% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -69 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.4m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -113 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 0.1% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | -41 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -89 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.9m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -136 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.3m | 0.6% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -695 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.0% | 1 | 0.5 | 0.2 | 0 | 0 | 0 | 4 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.0m | 0.0% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | -4 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.8m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -46 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.0m | 0.1% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | 30 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.4m | 0.1% | 1 | -1.0 | 0.2 | 0 | 0 | 0 | -167 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -26 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.4m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -11 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.8m | 0.7% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -640 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.4m | 0.2% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -32 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -72 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 1.5% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -3,949 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.8m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -38 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -171 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £3.9m | 0.6% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | -8 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.5m | 0.0% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | 8 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.9m | 0.0% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | 53 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.3m | 0.0% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -3 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.4m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -187 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.5m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -28 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.0m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -248 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.0m | 0.0% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | 45 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.4m | 0.0% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | -39 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.7m | 0.3% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | 843 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -54 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -52 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.4m | 0.1% | 1 | 0.3 | 0.2 | 0 | 0 | 0 | -81 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.3m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -65 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.8m | 0.2% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -331 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £3.9m | 2.5% | 1 | 0.0 | 0.3 | 0 | 0 | 0 | 1,880 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.8m | 0.0% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -8 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £5.3m | 0.1% | 1 | 0.0 | 0.2 | 0 | 0 | 0 | -114 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.9m | 0.0% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | -2 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.5m | 0.8% | 1 | 0.3 | 0.2 | 1 | 0 | 0 | 2,076 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -12 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -195 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £6.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -74 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £5.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -137 | NFO (A) EVE (H) LIV (A) HUL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -38 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 1.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,277 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -138 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -82 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.4m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -220 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £7.8m | 2.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,798 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -115 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -99 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -101 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -41 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2,142 | NEW (A) MCI (H) FUL (H) MUN (A) | |
| £4.0m | 3.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 295 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -100 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -101 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £7.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -114 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -12 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | SUN (H) MUN (A) LEE (H) IPS (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 75 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,916 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 73 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 92 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 410 | LIV (H) HUL (A) NFO (H) BHA (A) | |
| £4.0m | 4.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3,720 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -63 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -51 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 20 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 46 | CRY (H) LIV (A) MCI (A) BRE (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -65 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -34 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -86 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -200 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £5.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -321 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -397 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -182 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -71 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | EVE (A) TOT (H) MUN (H) SUN (A) | |
| £4.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,126 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -97 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.0m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -497 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £3.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 196 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £3.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 68 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -48 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -15 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -163 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -170 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -497 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.3m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -104 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -43 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.0m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 416 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 17 | TOT (A) FUL (H) SUN (H) EVE (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -27 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -31 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.0m | 1.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -355 | BHA (A) NEW (H) TOT (A) LIV (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 19 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -23 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -135 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -50 | CHE (H) ARS (A) NEW (A) COV (H) | |
| £4.0m | 1.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -104 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -121 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.4m | 1.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,166 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.5m | 5.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5,187 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -107 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.4m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2,226 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | HUL (H) COV (A) AVL (A) NEW (H) | |
| £4.0m | 1.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -272 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -43 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £3.9m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -304 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -211 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -58 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -57 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -335 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -48 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -60 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | FUL (A) BRE (H) IPS (H) ARS (A) | |
| £4.0m | 3.8% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,635 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.0m | 0.6% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -75 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £3.9m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -68 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -105 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 217 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -125 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -76 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.8m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -45 | MCI (A) NFO (H) HUL (A) BOU (H) | |
| £4.5m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -256 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 6 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -85 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -37 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -57 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -82 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 7 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.0m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 364 | MUN (H) SUN (A) BOU (A) TOT (H) | |
| £4.8m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -50 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -212 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 13 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 4 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -53 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -28 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -108 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -19 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -34 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 0 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -139 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £7.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -38 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 617 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -30 | BRE (A) BHA (H) ARS (H) CRY (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -17 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.2m | 0.4% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -423 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £6.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -4 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -104 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -34 | IPS (H) AVL (A) BHA (H) NFO (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -22 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -16 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -26 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -86 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -13 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -5 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -8 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.4m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 53 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.4m | 0.3% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -239 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.5m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2,181 | LEE (A) BOU (H) CHE (A) AVL (H) | |
| £4.9m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -332 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -11 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.8m | 0.7% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,098 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -78 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £5.4m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -3 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.5% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -868 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -355 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 406 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 82 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 3,568 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 38 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 42 | AVL (H) CRY (A) EVE (H) FUL (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -18 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -34 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.0m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -171 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -212 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -142 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -75 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -2 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.4m | 1.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -381 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -14 | ARS (H) IPS (A) BRE (A) MCI (H) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -157 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 41 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 16.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -6,512 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -50 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -198 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -7 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £3.9m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 1,207 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -21 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -51 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -227 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -9 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £5.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.9m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -147 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £6.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 10 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.4m | 0.9% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,368 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 1.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -1,972 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.5m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -64 | COV (H) CHE (A) CRY (H) LEE (A) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -84 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.4m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | 2 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -10 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.0m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -48 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.0m | 0.1% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -151 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.9m | 0.0% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -43 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.5m | 0.0% | 0 | 0.0 | 0.0 | 1 | 0 | 0 | -9 | BOU (A) LEE (H) COV (A) CHE (H) | |
| £4.5m | 0.2% | 0 | 0.0 | 0.0 | 0 | 0 | 0 | -169 | BOU (A) LEE (H) COV (A) CHE (H) |